论文部分内容阅读
目的评估复方阿嗪米特肠溶片对胆囊切除术后消化不良的临床疗效。方法 50例胆囊切除术后消化不良患者,随机分成观察组与对照组,各25例。对照组采用消化酶胶囊治疗;观察组采用复方阿嗪米特肠溶片治疗。观察两组患者症状变化情况。结果观察组治疗总有效率(92%)显著优于对照组(80%)(P<0.05),消化不良各项症状消失平均评分明显低于对照组(P<0.05)。不良反应发生率对比差异无统计学意义(P>0.05)。结论复方阿嗪米特肠溶片对胆囊切除术后消化不良治疗有效,临床推广价值高。
Objective To evaluate the clinical efficacy of compound azintamide enteric-coated tablets for dyspepsia after cholecystectomy. Methods 50 cases of dyspeptic patients after cholecystectomy were randomly divided into observation group and control group, 25 cases in each. The control group was treated with digestive enzyme capsules; the observation group was treated with compound azintamide enteric-coated tablets. The changes of symptoms in two groups were observed. Results The total effective rate (92%) in the observation group was significantly better than that in the control group (80%) (P <0.05). The mean scores of disappearance of symptoms of indigestion were significantly lower than those in the control group (P <0.05). There was no significant difference in the incidence of adverse reactions (P> 0.05). Conclusion The compound azinamid enteric-coated tablets is effective in the treatment of dyspepsia after cholecystectomy, and has high clinical value.